Raymond James Financial Services Advisors, Inc. Ngm Biopharmaceuticals Inc Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023
SELL
$1.05 - $3.37 $836 - $2,685
-797 Reduced 5.98%
12,538 $13,000
Q2 2023

Jul 25, 2023
SELL
$2.44 - $4.53 $53,855 - $99,986
-22,072 Reduced 62.34%
13,335 $34,000
Q1 2023

Apr 14, 2023
SELL
$3.72 - $5.4 $67,034 - $97,308
-18,020 Reduced 33.73%
35,407 $144,000
Q4 2022

Feb 08, 2023
SELL
$3.41 - $12.93 $107,275 - $406,764
-31,459 Reduced 37.06%
53,427 $268,000
Q3 2022

Oct 25, 2022
BUY
$12.59 - $17.67 $279,485 - $392,256
22,199 Added 35.41%
84,886 $1.11 Million
Q2 2022

Aug 12, 2022
BUY
$10.58 - $17.5 $355,445 - $587,930
33,596 Added 115.49%
62,687 $804,000
Q1 2022

May 11, 2022
BUY
$13.81 - $18.6 $401,746 - $541,092
29,091 New
29,091 $444,000
Q4 2020

Feb 12, 2021
SELL
$16.21 - $31.44 $227,863 - $441,952
-14,057 Closed
0 $0
Q3 2020

Nov 04, 2020
SELL
$15.59 - $19.97 $34,251 - $43,874
-2,197 Reduced 13.52%
14,057 $224,000
Q2 2020

Jul 17, 2020
BUY
$11.97 - $23.47 $194,560 - $381,481
16,254 New
16,254 $321,000

Others Institutions Holding NGM

# of Institutions
5
Shares Held
2.6M
Call Options Held
300
Put Options Held
0
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email